RS50735B - Medikamenti koji sadrže betamimetik lekove i novi lek antiholinesteraze - Google Patents

Medikamenti koji sadrže betamimetik lekove i novi lek antiholinesteraze

Info

Publication number
RS50735B
RS50735B YUP-898/04A YUP89804A RS50735B RS 50735 B RS50735 B RS 50735B YU P89804 A YUP89804 A YU P89804A RS 50735 B RS50735 B RS 50735B
Authority
RS
Serbia
Prior art keywords
medicaments containing
novel
anticholinesterase drug
betamimetic
drugs
Prior art date
Application number
YUP-898/04A
Other languages
English (en)
Inventor
Rolf Banholzer
Ingo Konetzki
Christopher J. Montague Meade
Helmut Meissner
Gerd Morschhäuser
Michel Pairet
Michael P. Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Publication of RS89804A publication Critical patent/RS89804A/sr
Publication of RS50735B publication Critical patent/RS50735B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Lek, naznačen time, što sadrži jednu ili više soli, formule 1 u kojoj X označava prost, negativno naelektrisan anjon, prvenstveno neki anjon, odabran iz grupe koju čine hlorid, bromid, jodid, sulfat,fosfat, metansulfonat, nitrat, maleat, acetat, citrat, fumarat, tartarat, oksalat, sukcinat, benzoat i p-toluolsulfonat, u kombinaciji sa jednim ili sa više betamimetika (2), u datom slučaju, u obliku svojih enentiomera, smeša enantiomera, ili u obliku racemata, u datom slučaju, u obliku solvata ili hidrata, kao i, u datom slučaju, sa nekim farmaceuski prihvat¬ljivim pomoćnim sredstvom. Prijava sadrži još 25 patentnih zahteva.
YUP-898/04A 2002-04-12 2003-04-09 Medikamenti koji sadrže betamimetik lekove i novi lek antiholinesteraze RS50735B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (de) 2002-04-12 2002-12-03 Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
PCT/EP2003/003669 WO2003087097A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend betamimetika und ein neues anticholinergikum

Publications (2)

Publication Number Publication Date
RS89804A RS89804A (en) 2006-10-27
RS50735B true RS50735B (sr) 2010-08-31

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-898/04A RS50735B (sr) 2002-04-12 2003-04-09 Medikamenti koji sadrže betamimetik lekove i novi lek antiholinesteraze

Country Status (19)

Country Link
EP (1) EP1497289B1 (sr)
JP (1) JP2005529111A (sr)
CN (1) CN1646527A (sr)
AT (1) ATE302774T1 (sr)
AU (1) AU2003232201B2 (sr)
BR (1) BR0309185A (sr)
CA (1) CA2481468C (sr)
DK (1) DK1497289T3 (sr)
ES (1) ES2248767T3 (sr)
HR (1) HRP20040944B1 (sr)
IL (1) IL164291A (sr)
MX (1) MXPA04009916A (sr)
NO (1) NO20044107L (sr)
NZ (1) NZ536337A (sr)
PL (1) PL213489B1 (sr)
PT (1) PT1497289E (sr)
RS (1) RS50735B (sr)
UY (1) UY27757A1 (sr)
WO (1) WO2003087097A1 (sr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
EP1577306A1 (de) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
JP5259193B2 (ja) 2005-02-25 2013-08-07 チエシイ・ファルマセウテイシイ・エス・ペー・アー 加圧下にある用量計量型吸入器用の金属イオン封鎖剤を含む薬用エーロゾル配合物
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
EP2281813A1 (en) 2005-08-08 2011-02-09 Pulmagen Therapeutics (Synergy) Limited Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
US10576222B2 (en) 2014-05-07 2020-03-03 Boehringer Ingelheim International Gmbh Container, indicator device with moveable piercing part, and nebulizer
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AU2003232201A1 (en) 2003-10-27
HRP20040944A2 (en) 2005-04-30
MXPA04009916A (es) 2005-05-03
RS89804A (en) 2006-10-27
PT1497289E (pt) 2005-11-30
CA2481468C (en) 2011-02-01
NZ536337A (en) 2007-05-31
HRP20040944B1 (en) 2012-12-31
DK1497289T3 (da) 2005-10-24
AU2003232201B2 (en) 2009-06-11
PL372450A1 (en) 2005-07-25
UY27757A1 (es) 2003-11-28
ES2248767T3 (es) 2006-03-16
PL213489B1 (pl) 2013-03-29
WO2003087097A1 (de) 2003-10-23
NO20044107L (no) 2004-11-04
EP1497289B1 (de) 2005-08-24
JP2005529111A (ja) 2005-09-29
CA2481468A1 (en) 2003-10-23
BR0309185A (pt) 2005-02-15
CN1646527A (zh) 2005-07-27
ATE302774T1 (de) 2005-09-15
IL164291A (en) 2012-04-30
IL164291A0 (en) 2005-12-18
EP1497289A1 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
WO2004037807A3 (en) Medicinal arylethanolamine compounds
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
WO2007117509A8 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
BR0009975B1 (pt) inalador de pà para um medicamento combinado.
MXPA06013221A (es) Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros.
MXPA03009849A (es) Uso de azitromicina para la fabricacion de un medicamento para el tratamiento de enfermedades inflamatorias no infecciosas.
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
PL1643999T3 (pl) Pirydoksamina do zastosowania w leczeniu nefropatii cukrzycowej w cukrzycy typu II
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
BR0307703A (pt) Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr
MXPA02009603A (es) Terapias de dosis divididas con actividad de deterioro vascular.
DE50115277D1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und
DK1581224T3 (da) Tiotropiumholdig lægemiddelsammensætning til inhalation
MY137679A (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
UY27686A1 (es) Nuevas sales del ácido cinámico, procedimientos para su preparación y su utilización como medicamentos.
LT2006026A (lt) 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimo pablogėjimui